Allurion Technologies ALURD
ALURD
$3.28 -0.11 (-3.24%)
At close: Aug 18, 2026 · 4:00 PM UTC

Allurion Technologies (ALURD) Income towards Parent Company (2022 - 2026)

Allurion Technologies' (ALURD) quarterly Income towards Parent Company came in at -$6.1 million in Q1 2026, down 306.06% YoY from $3.0 million in Q1 2025, and up 2.96% on a QoQ basis from -$6.3 million in Q4 2025.

Allurion Technologies (ALURD) Income towards Parent Company (2022 - 2026) Analysis & Trends

Allurion Technologies (ALURD) has 5 years of Income towards Parent Company data on file, last reported at -$6.1 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 306.06% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.6 million (down 206.61% YoY) and the FY2025 annual result came in at -$29.0 million, down 291.59% from the prior year.
  • Income towards Parent Company grew to -$6.1 million in Q1 2026, from -$6.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $8.7 million in Q3 2024 to a low of -$22.0 million in Q2 2023.
  • A 5-year average of -$9.8 million and a median of -$9.6 million in 2024 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2023 — Income towards Parent Company sank 306.96% — and 2024, when it jumped 140.25%.
  • Tracing ALURD's Income towards Parent Company over 5 years: stood at -$13.0 million in 2022, then tumbled by 64.36% to -$21.4 million in 2023, then surged by 54.17% to -$9.8 million in 2024, then surged by 35.93% to -$6.3 million in 2025, then gained by 2.96% to -$6.1 million in 2026.
  • The last three Income towards Parent Company figures came in at -$6.1 million (Q1 2026), -$6.3 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 Allurion Technologies 49.18 Mn 44.13 Mn 1.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.10 Mn
Dec 31, 2025 -6.28 Mn
Sep 30, 2025 -11.88 Mn
Jun 30, 2025 -9.34 Mn
Mar 31, 2025 -1.50 Mn
Dec 31, 2024 -9.80 Mn
Sep 30, 2024 8.71 Mn
Jun 30, 2024 -8.36 Mn
Mar 31, 2024 1.97 Mn
Dec 31, 2023 -21.39 Mn
Sep 30, 2023 -21.63 Mn
Jun 30, 2023 -22.00 Mn
Mar 31, 2023 -17.80 Mn
Dec 31, 2022 -13.01 Mn
Sep 30, 2022 -13.57 Mn
Jun 30, 2022 -5.41 Mn